The Stock Market Crash Will Destroy Lives: 2021 is the Dumbest Bubble In History...
https://youtu.be/onFT0vyiMKM
1.9 Trillion Trades on OTCMarkets in May. Thumbs up or Buyer Beware?
An increase of more than 2,000 percent from a year earlier!
Penny...
The Buffett Indicator. Tighten Your Safety Belts..
GDP's $22 Trillion vs Total Stock Market Value (TMC) of $50 Trillion
How Does This Compute (hint,...
ARK vs. SARK
Ever get really, really bearish and really, really wish you could find a simple way to make money in a bear market?
A Good Bear Market, is a Terrible Thing to Waste. How to Short Real...
"The commercial real estate market is tumbling toward a crash that could be as devastating as the 2008-09 crisis. The party’s over,...
Billions Lost in These Two Healthcare Spacs.
What Could Possibly go Wrong Investing in a Couple Billion Dollar Healthcare Giants?
Apparently Everything!
Short Selling Contest | Enter by September 30th.
Sep 18, 2023
Send entries to [email protected] by midnight Sept. 30. If you prefer old-fashioned mail, write to John...
The Retreat of the Amateur Investors (WSJ)
A pandemic boom attracted scores of Americans seeking gains. Now that some are backing away, the markets risk losing a key...
Bidenflation Hits Delray Beach Bars Hard.
First $5 gas, then $10 Drinks. Delray Beach Bar Goers Just say no! These are 'Prime Time'...
‘Big Short’ investor Michael Burry warns stocks will crash and rallies won’t last.
Here's a roundup of his recent tweets and what they mean. (BusinessInsider)
Michael Burry, the hedge fund manager...
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
